Nabriva Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update

-SIVEXTRO Distribution and Promotion Agreement with Merck Formally Extended Through at Least 2026-

-SIVEXTRO…

#sciencechatimba: double agents - how stomach stem cells change allegiance upon injury

A stomach adult stem cell population can fulfill two distinct functions: either help with digestion under normal…

Nabriva Extends Exclusive Agreement to Promote and Distribute SIVEXTRO® (tedizolid phosphate) in the U.S. Through the End of 2026

Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of…

Pharmig: Was grenzüberschreitende Datennutzung im Gesundheitsbereich bringt

Europäische Union setzt Startschuss für EU-Health-Data-Space. Positiver Nutzen der grenzüberschreitenden Datennutzung…

Valneva Initiates Heterologous Booster Trial of Inactivated, COVID-19 Vaccine Candidate

Valneva SE, a specialty vaccine company, today announced the initiation of a heterologous booster trial of its…

Uni Vienna: How octopuses and squid have broken away from the previously known pattern of evolution

The chromosomes of cephalopods differ greatly from those of any other group of animals

First Lithoz CeraFab Multi 2M30 in the UK delivered to government-backed research facility in Wales

- UK’s first Lithoz CeraFab Multi 2M30 has been installed at Compound Semiconductor Applications (CSA) Catapult…

„aws BoB Best of Biotech“ 2022 – Internationale Start-up Competition startet in die zehnte Runde

Bei aws BoB Best of Biotech werden aus ersten Ideen tragfähige Geschäftskonzepte. Einreichungen sind bis 29.07.2022…

Wiener Startup „reha buddy“ entwickelt medizinisches Hightech-Ganglabor für die Hosentasche

Die digitale Innovation von „reha buddy“ beschleunigt die Rehabilitation von Patienten. Nun startet eine…

HOOKIPA announces promotion of Christine D. Baker to Chief Operating Officer

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its…

Romana Ruda wird Business Development Director im Future Health Lab

em.Univ.Prof.Dr. Siegfried Meryn holt Romana Ruda ins Team des Future Health Lab